Advertisement

Journal of Clinical Immunology

, Volume 28, Issue 1, pp 44–49 | Cite as

The Influence of Polymorphisms of Interleukin-17A and Interleukin-17F Genes on the Susceptibility to Ulcerative Colitis

  • Tomiyasu Arisawa
  • Tomomitsu Tahara
  • Tomoyuki Shibata
  • Mitsuo Nagasaka
  • Masakatsu Nakamura
  • Yoshio Kamiya
  • Hiroshi Fujita
  • Masahiko Nakamura
  • Daisuke Yoshioka
  • Yuko Arima
  • Masaaki Okubo
  • Ichiro Hirata
  • Hiroshi Nakano
Article

Abstract

We investigated the association between ulcerative colitis (UC) and polymorphisms of IL-17A (rs2275913, G-197A) and IL-17F (rs763780, 7488T/C) genes. We employed the multiplex PCR-SSCP method to detect gene polymorphisms. Both the numbers of -197A (IL-17A) and 7488T (IL-17F) alleles were significantly correlated to the development of UC. The frequencies of -197A/A and 7488T/T genotypes in the UC group were significantly higher than those in the non-UC group. An adjusted analysis revealed that -197A and 7488T alleles were independent risk factors for the developing UC. In addition, both polymorphisms were significantly associated with the pancolitis phenotype. Furthermore, -197A allele was significantly correlated to the chronic relapsing phenotype and -197A/A homozygote was more frequent in steroid-dependent cases, whereas 7488T allele was correlated with the chronic continuous phenotype. Our results provided the first evidence that -197A (IL-17A) and 7488T (IL-17F) alleles may influence the susceptibility to and pathophysiological features of UC independently.

Keywords

Interleukin-17 (IL-17) single nucleotide polymorphism (SNP) ulcerative colitis 

References

  1. 1.
    Head KA, Jurenka JS. Inflammatory bowel disease part I: ulcerative colitis—pathophysiology and conventional and alternative treatment options. Altern Med Rev 2003;8:247–83.PubMedGoogle Scholar
  2. 2.
    Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, et al. Gene–environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 2003;100:3455–60.PubMedCrossRefGoogle Scholar
  3. 3.
    Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417–29.PubMedCrossRefGoogle Scholar
  4. 4.
    LakatosPL, Fischer S, Lakatos L, Gal I, Papp J. Current concept on the pathogenesis of inflammatory bowel disease—crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take “toll”? World J Gastroenterol 2006;12:1829–41.PubMedGoogle Scholar
  5. 5.
    Blumberg RS, Strober W. Prospects for research in inflammatory bowel diseases. JAMA 2001;285:643–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Tanaka M, Kazuma K. Ulcerative colitis: factors affecting difficulties of life and psychological well being of patients in remission. J Clin Nurs 2005;14:65–73.PubMedCrossRefGoogle Scholar
  7. 7.
    Newman B, Siminovitch KA. Recent advances in the genetics of inflammatory bowel disease. Curr Opin Gastroenterol 2005;21:401–7.PubMedGoogle Scholar
  8. 8.
    Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004;21:467–76.PubMedCrossRefGoogle Scholar
  9. 9.
    Kawaguchi M, Adachi M, Oda N, Kokubu F, Huang SK. IL-17 cytokine family. J Allergy Clin Immunol 2004;114:1265–74.PubMedCrossRefGoogle Scholar
  10. 10.
    Rutitzky LI, Lopes da Rosa JR, Stadecker MJ. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol 2005;175:3920–6.PubMedGoogle Scholar
  11. 11.
    Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003;278:1910–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233–40.PubMedCrossRefGoogle Scholar
  13. 13.
    Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133–41.PubMedCrossRefGoogle Scholar
  14. 14.
    Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003;171:6173–7.PubMedGoogle Scholar
  15. 15.
    Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003;198:1951–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003;52:65–70.PubMedCrossRefGoogle Scholar
  17. 17.
    Nielsen OH, Kirman I, Rudiger N, Hendel J, Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol 2003;38:180–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Zhang Z, Hinrichs DJ, Lu H, Chen H, Zhong W, Kolls JK. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease? Int Immunopharmacol 2007;7:409–16.PubMedCrossRefGoogle Scholar
  19. 19.
    Kawaguchi M, Takahashi D, Hizawa N, Suzuki S, Matsukura S, Kokubu F, et al. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol 2006;117:795–801.PubMedCrossRefGoogle Scholar
  20. 20.
    Podolsky DK. Inflammatory bowel disease 2. N Engl J Med 1991;325:928–37.PubMedCrossRefGoogle Scholar
  21. 21.
    Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al. The relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis. Int J Mol Med 2007;19:143–8.PubMedGoogle Scholar
  22. 22.
    Santucci L, Agostini M, Bruscoli S, Mencarelli A, Ronchetti S, Ayroldi E, et al. GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut 2007;56:52–60.PubMedCrossRefGoogle Scholar
  23. 23.
    Ohteki T. Critical role for IL-15 in innate immunity. Curr Mol Med 2002;2:371–80.PubMedCrossRefGoogle Scholar
  24. 24.
    Lankford CS, Frucht DM. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003;73:49–56.PubMedCrossRefGoogle Scholar
  25. 25.
    Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995;155:5483–6.PubMedGoogle Scholar
  26. 26.
    Li H, Chen J, Huang A, Stinson J, Heldens S, Foster J, et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA 2000;97:773–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, Broxmeyer HE, et al. Cutting edge. IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 2001;167:4137–40.PubMedGoogle Scholar
  28. 28.
    Starnes T, Broxmeyer HE, Robertson MJ, Hromas R. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 2002;169:642–6.PubMedGoogle Scholar
  29. 29.
    Lee J, Ho WH, Maruoka M, Corpuz RT, Baldwin DT, Foster JS, et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 2001;276:1660–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Chabaud M, Lubberts E, Joosten L. van Den Berg W, Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res 2001;3:168–77.PubMedCrossRefGoogle Scholar
  31. 31.
    Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredyikson S, et al. Interleukin-17 mRNA expression in blood and CSF-mononuclear cells is augmented in multiple sclerosis. Mult Scler 1999;5:101–4.PubMedGoogle Scholar
  32. 32.
    Ramsey CD, Lazarus R, Camargo Jr CA, Weiss ST, Celedon JC. Polymorphisms in the interleukin 17F gene (IL17F) and asthma. Genes Immun 2005;6:236–41.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Tomiyasu Arisawa
    • 1
  • Tomomitsu Tahara
    • 1
  • Tomoyuki Shibata
    • 1
  • Mitsuo Nagasaka
    • 1
  • Masakatsu Nakamura
    • 1
  • Yoshio Kamiya
    • 1
  • Hiroshi Fujita
    • 1
  • Masahiko Nakamura
    • 1
  • Daisuke Yoshioka
    • 1
  • Yuko Arima
    • 1
  • Masaaki Okubo
    • 1
  • Ichiro Hirata
    • 1
  • Hiroshi Nakano
    • 1
  1. 1.Department of GastroenterologyFujita Health University School of MedicineToyoakeJapan

Personalised recommendations